Laura Agensky
Plus aucun poste en cours
Historique de carrière de Laura Agensky
Anciens postes connus de Laura Agensky
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRANSITION THERAPEUTICS INC | Directeur des opérations | 18/06/2009 | 21/06/2009 |
| Directeur Technique/Scientifique/R&D | 21/06/2009 | 04/08/2010 | |
| Corporate Officer/Principal | 04/08/2010 | - |
Formation de Laura Agensky
| McGill University | Masters Business Admin |
Statistiques
Internationale
| Canada | 3 |
Opérationnelle
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
- Bourse
- Insiders
- Laura Agensky
- Expérience
